Accelerated phase chronic myeloid leukemia

disorder

SNOMED 413389003CUI C0023472

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Imatinib mesylate

substance

Nilotinib

substance

Nilotinib hydrochloride monohydrate

substance

Nilotinib hydrochloride

substance

Related Conditions

Chronic myeloid leukemia(parent)

Quick Facts

SNOMED CT: 413389003
UMLS CUI: C0023472
Fully Specified Name: Accelerated phase chronic myeloid leukemia (disorder)
Specialists: 0
Diagnostic Biomarkers: 0
Known Treatments: 4

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.